FierceBiotech

AzurRx boosts GI pipeline through First Wave buyout worth up to $229M

AzurRx is bolstering its pipeline and assuming a new name through its acquisition of First Wave Bio. The cash-and-stock deal could be worth up to $229 million and includes future payments if ...
Healio

Top in GI: Drug pipeline for GI conditions; concerns over physician shortage

Please provide your email address to receive an email when new articles are posted on . There were several important FDA approvals for GI conditions over the past year, including the first treatment ...
Yahoo Finance

Applied Molecular Transport Expands Clinical Pipeline and Announces First Subject Dosed in Phase 1a Trial of Oral AMT-126

SOUTH SAN FRANCISCO, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the first in human ...
Seeking Alpha

Palisade Bio Transforms GI-Focused Pipeline Through Exclusive Worldwide Licensing Agreement with Giiant Pharma, Inc. for Multiple Oral Drug Candidates Targeting Inflammatory ...

– Lead program, GT-2108 for the treatment of moderate-to-severe ulcerative colitis advancing toward completion of I ND-enabling studies with IND filing expected by Q3 2024 Carlsbad, CA, Sept. 06, 2023 ...
Seeking Alpha

First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline

BOCA RATON, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc.,, (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development ...